Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Wolf

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
General Pharmacology|January 1, 1988
Studies of the in vitro human plasma degradation of methionine-enkephalinA D Mosnaim, J Puente, M E Wolf, et al.
Neurology|June 1, 2011
Clinical and MRI characteristics of acute migrainous infarctionM E Wolf, K Szabo, M Griebe, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1993
In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2J Puente, T Carvajal, S Parra, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 1982
Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjectsA D Mosnaim, F Karoum, A Zeller, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studiesJ Puente, T Carvajal, S Parra, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 1, 2013
The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping)P Amarenco, J Bogousslavsky, L R Caplan, et al.
Immunopharmacology|March 1, 1993
In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challengeA D Mosnaim, M E Wolf, P Maturana, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Studies of natural killer cell activity in a drug-free, healthy population. Response to a challenge with taxol, estramustine and lipopolysaccharideJ Puente, M Diaz, M A Salas, et al.
Cephalalgia : an International Journal of Headache|June 27, 1998
Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attackA D Mosnaim, H Kulaga, A J Adams, et al.
American Journal of Preventive Medicine|July 1, 1993
Use of behavioral risk factor surveys to predict alcohol-related motor vehicle eventsD C Thompson, F P Rivara, R S Thompson, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
General Pharmacology|January 1, 1988
Studies of the in vitro human plasma degradation of methionine-enkephalinA D Mosnaim, J Puente, M E Wolf, et al.
Neurology|June 1, 2011
Clinical and MRI characteristics of acute migrainous infarctionM E Wolf, K Szabo, M Griebe, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1993
In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2J Puente, T Carvajal, S Parra, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 1982
Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjectsA D Mosnaim, F Karoum, A Zeller, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studiesJ Puente, T Carvajal, S Parra, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 1, 2013
The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping)P Amarenco, J Bogousslavsky, L R Caplan, et al.
Immunopharmacology|March 1, 1993
In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challengeA D Mosnaim, M E Wolf, P Maturana, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Studies of natural killer cell activity in a drug-free, healthy population. Response to a challenge with taxol, estramustine and lipopolysaccharideJ Puente, M Diaz, M A Salas, et al.
Cephalalgia : an International Journal of Headache|June 27, 1998
Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attackA D Mosnaim, H Kulaga, A J Adams, et al.
American Journal of Preventive Medicine|July 1, 1993
Use of behavioral risk factor surveys to predict alcohol-related motor vehicle eventsD C Thompson, F P Rivara, R S Thompson, et al.
Pageof 15